Literature DB >> 22688718

Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery.

Rinki Ratna Priya1, Harsha Karur Rajasimha, Matthew J Brooks, Anand Swaroop.   

Abstract

In humans, protein-coding exons constitute 1.5-1.7% of the human genome. Targeted sequencing of all coding exons is termed as exome sequencing. This method enriches for coding sequences at a genome-wide scale from 3 μg of DNA in a hybridization capture. Exome analysis provides an excellent opportunity for high-throughput identification of disease-causing variations without the prior knowledge of linkage or association. A comprehensive landscape of coding variants could also offer valuable mechanistic insights into phenotypic heterogeneity and genetic epistasis.

Entities:  

Mesh:

Year:  2012        PMID: 22688718     DOI: 10.1007/978-1-61779-848-1_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Next generation sequencing technology and genomewide data analysis: Perspectives for retinal research.

Authors:  Vijender Chaitankar; Gökhan Karakülah; Rinki Ratnapriya; Felipe O Giuste; Matthew J Brooks; Anand Swaroop
Journal:  Prog Retin Eye Res       Date:  2016-06-11       Impact factor: 21.198

2.  OTX2 loss causes rod differentiation defect in CRX-associated congenital blindness.

Authors:  Jerome E Roger; Avinash Hiriyanna; Norimoto Gotoh; Hong Hao; Debbie F Cheng; Rinki Ratnapriya; Marie-Audrey I Kautzmann; Bo Chang; Anand Swaroop
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 3.  Genetic architecture of retinal and macular degenerative diseases: the promise and challenges of next-generation sequencing.

Authors:  Rinki Ratnapriya; Anand Swaroop
Journal:  Genome Med       Date:  2013-10-11       Impact factor: 11.117

Review 4.  Age-related macular degeneration-clinical review and genetics update.

Authors:  R Ratnapriya; E Y Chew
Journal:  Clin Genet       Date:  2013-08       Impact factor: 4.438

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.